These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 36012132)

  • 1. Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
    Cincotta AH; Cersosimo E; Alatrach M; Ezrokhi M; Agyin C; Adams J; Chilton R; Triplitt C; Chamarthi B; Cominos N; DeFronzo RA
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.
    Ezrokhi M; Zhang Y; Luo S; Cincotta AH
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus.
    Chamarthi B; Gaziano JM; Blonde L; Vinik A; Scranton RE; Ezrokhi M; Rutty D; Cincotta AH
    J Diabetes Res; 2015; 2015():157698. PubMed ID: 26060823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
    Cincotta AH
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.
    Chamarthi B; Ezrokhi M; Rutty D; Cincotta AH
    Postgrad Med; 2016 Nov; 128(8):761-769. PubMed ID: 27687032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.
    Gaziano JM; Cincotta AH; Vinik A; Blonde L; Bohannon N; Scranton R
    J Am Heart Assoc; 2012 Oct; 1(5):e002279. PubMed ID: 23316290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary.
    Raskin P; Cincotta AH
    Expert Rev Endocrinol Metab; 2016 Mar; 11(2):113-148. PubMed ID: 30058874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus.
    Schwartz SS; Zangeneh F
    Postgrad Med; 2016 Nov; 128(8):828-838. PubMed ID: 27458683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes.
    Szpigel A; Hainault I; Carlier A; Venteclef N; Batto AF; Hajduch E; Bernard C; Ktorza A; Gautier JF; Ferré P; Bourron O; Foufelle F
    Diabetologia; 2018 Feb; 61(2):399-412. PubMed ID: 28988346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
    Chamarthi B; Cincotta AH
    Postgrad Med; 2017 May; 129(4):446-455. PubMed ID: 28374645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus.
    Chamarthi B; Vinik A; Ezrokhi M; Cincotta AH
    Endocrinol Diabetes Metab; 2020 Jan; 3(1):e00101. PubMed ID: 31922028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine: does this drug of Parkinson's disease have a role in managing cardiovascular diseases?
    Kutikuppala LVS; Sharma S; Chavan M; Rangari G; Misra AK; Innamuri SR; Vijayakumar T; Varshitha G
    Ann Med Surg (Lond); 2024 Feb; 86(2):926-929. PubMed ID: 38333315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation.
    Palová-Jelínková L; Dáňová K; Drašarová H; Dvořák M; Funda DP; Fundová P; Kotrbová-Kozak A; Černá M; Kamanová J; Martin SF; Freudenberg M; Tučková L
    PLoS One; 2013; 8(4):e62426. PubMed ID: 23658628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal hypothyroidism causes oxidative stress and endoplasmic reticulum stress in the maternal-fetal interface of rats.
    Dos Anjos Cordeiro JM; Santos LC; de Oliveira LS; Santos BR; Santos EO; Barbosa EM; de Macêdo IO; de Freitas GJC; Santos DA; de Lavor MSL; Silva JF
    Free Radic Biol Med; 2022 Oct; 191():24-39. PubMed ID: 36038036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes.
    Savchenko LG; Digtiar NI; Selikhova LG; Kaidasheva EI; Shlykova OA; Vesnina LE; Kaidashev IP
    Rom J Intern Med; 2019 Sep; 57(3):233-240. PubMed ID: 30901315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Expression of the Innate Immune Receptor TLR10 in Obesity and Type-2 Diabetes: Association with ROS-Mediated Oxidative Stress.
    Sindhu S; Akhter N; Kochumon S; Thomas R; Wilson A; Shenouda S; Tuomilehto J; Ahmad R
    Cell Physiol Biochem; 2018; 45(2):572-590. PubMed ID: 29428931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell.
    Pitanga TN; Oliveira RR; Zanette DL; Guarda CC; Santiago RP; Santana SS; Nascimento VML; Lima JB; Carvalho GQ; Maffili VV; Carvalho MOS; Alcântara LCJ; Borges VM; Goncalves MS
    Cytokine; 2016 Jul; 83():75-84. PubMed ID: 27045344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters.
    Lamos EM; Levitt DL; Munir KM
    Prim Care Diabetes; 2016 Feb; 10(1):60-5. PubMed ID: 26670921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canna x generalis L.H. Bailey rhizome extract ameliorates dextran sulfate sodium-induced colitis via modulating intestinal mucosal dysfunction, oxidative stress, inflammation, and TLR4/ NF-ҡB and NLRP3 inflammasome pathways.
    Mahmoud TN; El-Maadawy WH; Kandil ZA; Khalil H; El-Fiky NM; El Alfy TSMA
    J Ethnopharmacol; 2021 Apr; 269():113670. PubMed ID: 33301917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes.
    Gaziano JM; Cincotta AH; O'Connor CM; Ezrokhi M; Rutty D; Ma ZJ; Scranton RE
    Diabetes Care; 2010 Jul; 33(7):1503-8. PubMed ID: 20332352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.